Department of Medico Surgical Sciences and Biotechnologies Sapienza University of Rome Latina Italy

Department of Neurology Charles University Prague 2nd Faculty of Medicine University Hospital Motol Prague Czech Republic

Division of Cardiology University of Turin Città Della Salute e Della Scienza Torino Italy

Mid America Heart Institute St Luke's Hospital Kansas City Missouri USA

St Luke's Roosevelt Hospital Center New York New York USA

The Heart Hospital University College London Hospitals UCLH London UK ; Yale Medical School New Haven Connecticut USA

Open Heart. 2014;1(1):e000134corr1 PubMed

Zobrazit více v PubMed

Granger CB, Alexander JH, McMurray JJ, et al. ; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981–92 PubMed

Alexander JH, Lopes RD, Thomas L, et al. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J 2014;35:224–32 PubMed

Linkins LA, Choi P, Douketis JD. Clinical impact of Bleeding in patients taking oral anticoagulation therapy for venous thromboembolism: a meta analysis. Ann Intern Med 2003;139:893–900 PubMed

Carrier M, Le Gal G, Wells PS, et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010;152:578–89 PubMed

Douketis JD. Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why? Thromb Res 2011;127:513–17 PubMed

Ezekowitz MD, Reilly PA, Nehmiz G, et al. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol 2007;100:1419–26 PubMed

DiNicolantonio JJ. Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial. Expert Opin Pharmacother 2012;13:1–11 PubMed

Ansara AJ, Nisly SA, Arif SA, et al. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature. Ann Pharmacother 2010;44:851–62 PubMed

[No authors listed] Stroke prevention in atrial fibrillation study. Circulation 1991;84:527–39 PubMed

Connolly SJ, Eikelboom J, Joyner C, et al. ; AVERROES Steering Committee and investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806–17 PubMed